Answers are grounded in this paper and cite their sources.
Recently, millions of people have been affected by neurodegenerative diseases globally (Tambasco, Romoli & Calabresi, 2018).Researchers have shown that a mix of an individual's genetic makeup and environmental circumstances can contribute equally to increasing the risk for NDs, even if age is the most critical risk factor for developing all NDs (Bloem, Okun & Klein, 2021).The severity and timing of neurodegeneration also heavily depend on the local environment, despite the expression of specif-PriMera Scientific Surgical Research and Practice https://primerascientific.com/pssrp White Paper on Neurodegenerative Disease and Related Disorders and Associated Case Study 32 ic genes responsible for NDs (Delamarre & Meissner, 2017).Recent research has shown that many other disorders may accompany a single neurodegenerative illness.Therefore, the severity of NDs depends purely on the nature and stage of the disease; in some cases, they may even be life-threatening (Mathis et al., 2020).These disorders thus impair numerous elements of human functioning and impede the capacity to accomplish simple and complex tasks since the brain regulates several bodily functions.While the majority of these conditions proceed without remission, some treatments aim to lessen symptoms, relieve any pain that may be present, and restore balance and mobility (Vázquez-Vélez & Zoghbi, 2021).This review comprehensively discusses the numerous NDs (Parkinson's disease, Amyotrophic lateral sclerosis, and Alzheimer's disease with the case study), their alternative treatments and the effectiveness of integrated approaches for management.
No takes yet. Share an insight, caveat, or question.
Christina Rahm (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: